This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Investigators from the Boston Medical Center (BMC) and the CDC conducted a study to assess rates of testing for hepatitis C virus (HCV) among pregnant women with a history of opioid use and their children. Study participants were women who were enrolled in the Recovery, Empowerment, Social Services, Perinatal care, Education and Community and Treatment (RESPECT) program at BMC who had a diagnosis of opioid use disorder and delivered a live baby between 2006 and 2015. Data from the RESPECT program registry, including demographic characteristics, medical history, and birth outcomes, were abstracted for the study. In addition, the medical records of participants and their offspring were reviewed to determine HCV-related laboratory test results, such as HCV antibody (anti-HCV) testing, nucleic acid testing (ribonucleic acid [RNA]), and HIV …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Purchase access
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.